Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00QEP
|
||||
Former ID |
DNCL002400
|
||||
Drug Name |
Inotuzumab ozogamicin
|
||||
Drug Type |
Antibody
|
||||
Company |
Pfizer New York, NY
|
||||
CAS Number |
CAS 635715-01-4
|
||||
Target and Pathway | |||||
Target(s) | B-cell receptor CD22 | Target Info | [532335] | ||
PANTHER Pathway | B cell activation | ||||
Pathway Interaction Database | BCR signaling pathway | ||||
WikiPathways | B Cell Receptor Signaling Pathway | ||||
References | |||||
Ref 543021 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8266). | ||||
Ref 547545 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017171) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.